active juvenile idiopathic arthritis, either alone or in combination with corticosteroids, in adult patients refractory or intolerant to thiopurines., inteneded for treatment of - active rheumatoid arthritis in adult patients, - mild-to-moderate Crohn’s disease, - polyarthritic forms of severe, - severe recalcitrant disabling psoriasis which is not adequately responsive to other forms of therapy and severe psoriatic arthritis in adult patients, when the response to nonsteroidal anti-inflammatory drugs has been inadequate
Conditions
Interventions
None listed
Sponsors
Gebro Pharma GmbH
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Countries
Czechia
Outcome results
None listed